國鼎生物科技股份有限公司 Approved
最後更新時間 2025/07/10 , 11:19 PM
最後更新時間 2025/07/10 , 11:19 PM
負責人
Liu,Sheng-Yong
統一編號
80280616
成立日期
2002/09/27
資本額
NT$2,000,000,000
實收資本額
NT$1,622,270,000
股票代號
4132
電話
02-28086006
地址
10F, No. 9, Ln. 3, Sec. 1, Zhongzheng E. Rd., Tamsui Dist., New Taipei City, 251, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Liu,Sheng-Yong Chairman 0.57%
Chen,Yu-Qun Vice Chairman 0.96%
Wu,Li-Yu Director 2.92%
Liao,Yu-Hui Director 0.64%
Xu,Xing-Hao Director 1.53%
Li,Ji-Cun Independent Director 0.00%
Xu,Wen-Wei Independent Director 0.00%
營業項目
  • Research and Experimental Development on Natural Sciences and Engineering(721000)
  • 公司歷程
  • Change Capital to 2,000,000,000
    2017/02/17
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 22,953 63,429 217,825
    Operating cost 20,413 47,373 66,033
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 2,540 16,056 151,792
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 2,540 16,056 151,792
    Operating expenses 163,593 381,638 448,561
    Other gain (loss), net - - -
    Operating profit (loss) -161,053 -365,582 -296,769
    Non-operating income and expenses 255 4,233 25,008
    Net profit (loss) before tax -160,798 -361,349 -271,761
    Income tax expense (benefits) 0 293 116
    Net profit (loss) of ongoing business for the current period -160,798 -361,642 -271,877
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -160,798 -361,642 -271,877
    Other comprehensive profit (loss), net -586 -928 687
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -161,384 -362,570 -271,190
    Net profit (loss) attributable to owners of parent company -160,798 -361,642 -271,877
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company -161,384 -362,570 -271,190
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) -1 -2 -1
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -135,661 -271,316 -245,903
    Net cash inflows (outflows) from investing activities -10,941 -18,637 63,470
    Net cash inflow (outflow) from financing activities 25,652 -21,796 -26,316
    Effect of Exchange Rate Changes on Cash and Cash Equivalents -581 -848 667
    Increase (decrease) in cash and cash equivalents in the current period -121,531 -312,597 -208,082
    Beginning balance of cash and cash equivalents 210,888 523,485 731,567
    Ending balance of cash and cash equivalents 89,357 210,888 523,485
    項目 2024 2023 2022
    Current asset 194,308 324,364 689,625
    Non-current asset 383,646 389,850 413,745
    Total asset 577,954 714,214 1,103,370
    Current liability 300,736 285,463 302,226
    Non-current liability 36,498 26,647 36,470
    Total liability 337,234 312,110 338,696
    share capital 1,422,270 1,422,270 1,422,270
    Equity - secruity token - - -
    capital reserve - 0 0
    retained earning -1,172,927 -1,012,129 -650,424
    Other equity -8,623 -8,037 -7,172
    Treasury stock - - -
    Total equity attributable to owners of parent company 240,720 402,104 764,674
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 240,720 402,104 764,674
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 1 2 5
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 賀先拿
  • LiVERTY設計圖
  • 國鼎力提
  • PaPa-Formula
  • 爸爸方程式PaPa-Formula
  • 載能ZSAINO
  • 國鼎萜慕珍
  • Triter-King
  • 國鼎安卓強
  • Riminder
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Compensation for damage
    2018, 2019
  • Confirmation of the existence of employment relationship
    2015
  • Confirmation of the existence of employment relationship, etc
    2018
  • Payment order
    2011
  • Petition for trial
    2021
  • Invalidating Judgment
    2008
  • Compensation for damage
    2016, 2019, 2020, 2021
  • Petition filed for public summons
    2008
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。